Genetically-engineered bone marrow stromal cells and collagen mimetic scaffold modification for healing critically-sized bone defects
Non-healing bone defects have a significant socioeconomic impact in the U.S. with approximately 600,000 bone grafting procedures performed annually. Autografts and allografts are clinically the most common treatments; however, autologous donor bone is in limited supply, and allografts often have po...
Main Author: | Wojtowicz, Abigail M. |
---|---|
Published: |
Georgia Institute of Technology
2010
|
Subjects: | |
Online Access: | http://hdl.handle.net/1853/34705 |
Similar Items
-
Role of Percutaneous Bone Marrow Aspirate Injection in Delayed Union of Femur and Tibia Diaphyseal Fractures
by: Rizwan H. Malik et al.,
Published: (2018-09-01) -
Roles of MicroRNAs in Osteogenesis or Adipogenesis Differentiation of Bone Marrow Stromal Progenitor Cells
by: Ya-Li Zhang, et al.
Published: (2021-07-01) -
Native bovine bone morphogenetic protein in the healing of segmental long bone defects
by: Tuominen, T. (Tapio)
Published: (2001) -
Evaluation of rhBMP-2/collagen/TCP-HA bone graft with and without bone marrow cells in the canine femoral multi defect model
by: V Luangphakdy, et al.
Published: (2015-01-01) -
An Innovative Bioceramic Bone Graft Substitute for Bone Defect Treatment: In Vivo Evaluation of Bone Healing
by: Syamsiah Syam, et al.
Published: (2020-11-01)